Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Finelli, Carmine | - |
dc.contributor.author | Martelli, Giuseppe | - |
dc.contributor.author | Rossano, Rocco | - |
dc.contributor.author | Padula, Maria Carmela | - |
dc.contributor.author | La Sala, Nicolina | - |
dc.contributor.author | Sommella, Luigi | - |
dc.contributor.author | Tarantino, Giovanni | - |
dc.date.accessioned | 2014-07-25T08:58:01Z | - |
dc.date.available | 2014-07-25T08:58:01Z | - |
dc.date.issued | 2014-05-26 | - |
dc.identifier.issn | 1611-2156 | - |
dc.identifier.uri | http://hdl.handle.net/2003/33547 | - |
dc.identifier.uri | http://dx.doi.org/10.17877/DE290R-824 | - |
dc.description.abstract | In this article, we review on the current concepts about Nesfatin-1 as a new anti-obesity treatment and evaluate the existing issues in the context of this knowledge and the available literature. The intent is to enable clinicians to know Nesfatin-1 as a new anti-obesity treatment and make rational decisions based on this perspective as possible clinical application. Future research should seek to clarify whether Nesfatin-1 would be beneficial in the management of obesity. | en |
dc.language.iso | en | - |
dc.relation.ispartofseries | EXCLI Journal ; Vol. 13, 2014 | en |
dc.subject | nesfatin-1 | en |
dc.subject | obesity | en |
dc.subject | drug treatment | en |
dc.subject.ddc | 610 | - |
dc.title | Nesfatin-1 | en |
dc.title.alternative | role as possible new anti-obesity treatment | en |
dc.type | Text | - |
dc.type.publicationtype | article | - |
dcterms.accessRights | open access | - |
eldorado.dnb.zdberstkatid | 2132560-1 | - |
Appears in Collections: | Review Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Finelli_26052014_proof.pdf | DNB | 89.73 kB | Adobe PDF | View/Open |
This item is protected by original copyright |
This item is protected by original copyright rightsstatements.org